Multispecialty
COVID-19 news is changing rapidly and we are all trying to stay on top of the latest medical information from trusted sources. Join experts in the medical field for free CME webinars covering what we know about the coronavirus outbreak.
4/14/2021 - Johnson & Johnson Vaccine Pause
Dr. Paul Auwaerter gives us an update on COVID-19 vaccines including the United States pause on the use of the Johnson & Johnson vaccine. Topics: *CDC & FDA recommendation to pause J&J/Janssen vaccine *Potential side effect of AstraZeneca ChAd vaccine *AstraZeneca (Vaxzevria) use in Europe by age *Does hormonal birth control play a role in the J&J vaccine incidents?
Faculty
Paul G. Auwaerter, MD, MBA, FIDSA
Clinical Director, Division of Infectious Diseases
Sherrilyn and Ken Fisher Professor of Medicine
Fisher Center for Environmental Infectious Diseases
Johns Hopkins University School of Medicine
View All
In support of improving patient care, this activity has been planned and implemented by the Postgraduate Institute for Medicine and DKBmed. Postgraduate Institute for Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
The Postgraduate Institute for Medicine has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 0.25 AAPA Category 1 CME credits. Approval is valid until April 14, 2022. PAs should only claim credit commensurate with the extent of their participation.
Postgraduate Institute for Medicine designates this continuing education activity for .25 contact hour(s) (0.25 CEUs) of the Accreditation Council for Pharmacy Education.